The Valley Desk

Clinical trial reportJournal of clinical oncology : official journal of the American Society of Clinical OncologyPublished

Results From First-in-Human Phase I Dose-Escalation Study of a Novel Bicycle Toxin Conjugate Targeting EphA2 (BT5528) in Patients With Advanced Solid Tumors

Read the publication ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published
Subject terms
Humans; Neoplasms; Peptides, Cyclic; Receptor, EphA2; Oligopeptides; Maximum Tolerated Dose; Dose-Response Relationship, Drug; Adult; Aged; Aged, 80 and over; Middle Aged; Female
PubMed ID
39231383
Added to directory
Source checked

Report a correction or request removal